Search

Filters
Clear All
  • 16
  • 55
  • 1
  • 686

Phase

  • 12
  • 17
  • 62
  • 8
  • 78
  • 3
  • 551
  • 668
  • 295
  • 736
  • 22
  • 1
  • 757

Found 758 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
Liver Research Study for Heavy Drinkers
R
Raj Vuppalanchi, MD
18 years - 75 years
All genders
Phase 2
Interventional
Do you have liver damage because of excessive alcohol use?  Join our study!Researchers at the Indiana University School of Medicine are looking for adult volunteers to take part in a study looking at the link between heavy drinking and liver disease.Your participation may help researchers to gain knowledge that may …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2/3
This study investigates the effects of adding an investigational medication, cemiplimab, to the usual treatment of docetaxel and ramucirumab for patients with stage IV or recurrent non-small cell lung cancer. This type of lung cancer is advanced and may have returned after previous treatment. Cemiplimab is a monoclonal antibody that …
K
Kathy Miller, MD
18 years - 100 years
All genders
This study investigates the financial barriers faced by breast cancer patients who participate in clinical trials. Breast cancer is a disease where cells in the breast grow uncontrollably. This study looks at costs like lost income, travel, and parking for patients enrolled in these trials.Participants will complete a one-time paper …
Steps Toward Recovery: Walk in Virtual Reality for Stroke and TBI Therapy
P
Peter Altenburger
18 years or above
All genders
Interventional
Could Virtual Reality (VR) Help You Walk Better? Join a Walking VR Therapy Study for Stroke and TBI Survivors and Help Us Find Out!Researchers at Indiana University are studying how virtual reality (VR) therapy may help improve your walking.We are inviting adults (18+) who have had a traumatic brain injury (TBI) …
A
Anita Turk, MD
18 years - 100 years
All genders
This study investigates the safety and effects of an investigational medication in combination with other agents for patients with pancreatic or non-small cell lung cancer. These cancers are being studied because they have specific genetic changes called MTAP loss and RAS mutation. The purpose is to see how the investigational …
N
Nabil Adra, MD
15 years - 100 years
All genders
Phase 1
This study investigates the safety and tolerability of an investigational medication in people with advanced solid tumors. Advanced solid tumors are cancers that have spread and are difficult to treat. The purpose of this study is to find out if the investigational medication is safe and to determine the best …
M
Misty D. Shields, MD, PhD
18 years - 100 years
All genders
This study investigates the use of an investigational medication compared to durvalumab for people with limited-stage small-cell lung cancer (SCLC). Small-cell lung cancer is a type of cancer that starts in the lungs and is known for growing quickly. Participants in this study have already received chemotherapy and radiotherapy, which …
N
Nabil Adra, MD
18 years - 100 years
All genders
This study investigates circulating tumor DNA (ctDNA) in patients with high-risk stage I and clinical stage II germ cell tumors. Circulating tumor DNA is a biomarker that helps show how the body responds to cancer treatments. By collecting blood and tissue samples, researchers aim to see if ctDNA can be …
J
Jennifer King
18 years - 100 years
All genders
Phase 3
This study investigates treatments for advanced clear cell renal cell carcinoma, a type of kidney cancer. The purpose of this study is to compare the effects of an investigational medication combined with cabozantinib versus a placebo combined with cabozantinib. Participants in this study have advanced or metastatic clear cell renal …
K
Khushali Jhaveri
18 years - 100 years
All genders
Phase 3
This study investigates the effectiveness of two treatments for people with a type of cancer called follicular lymphoma, which affects certain white blood cells. The purpose of this study is to compare an investigational medication with rituximab, which is a monoclonal antibody that attaches to a protein on cancer cells …
131 - 140 of 758